Trials / Completed
CompletedNCT00184223
Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose for this study is to determine whether 2x45 minutes Motivational Interviewing given during hospital stay to acutely admitted psychiatric patients with substance use problems, can reduce substance use after discharge.
Detailed description
The aims of the study are in a randomized controlled trial to compare the effects of 2 x 45 minutes Motivational Interviewing and standard treatment with standard treatment alone.All patients acutely admitted to Østmarka Psychiatric Hospital are evaluated for substance use, and all patients with substance use that give their consent to participate are randomized to Motivational Interviewing and standard treatment or standard treatment alone. Substance use and function will be followed for two years.Admittances to hospital and contacts with primary health care for five years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Motivational Interviewing | 2 sessions of 45 minutes each with manual guided motivational interviewing delivered individually by a trained therapist. |
| OTHER | Treatment as usual | Treatment as usual is individualized according to the clinical condition of the patients during the stay and in accordance with general national and international medical standards. It includes detoxification, pharmacotherapy, and general psychotherapy. Also, treatment is given for any coexisting non-substance-related disorder, including psychiatric disorders. |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2005-06-01
- Completion
- 2005-06-01
- First posted
- 2005-09-16
- Last updated
- 2016-06-06
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00184223. Inclusion in this directory is not an endorsement.